Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Chicken Fatty Acid Binding Protein 2, Intestinal (FABP2), N-His

Cat. No.AP7F313

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Chicken Fatty Acid Binding Protein 2, Intestinal (FABP2), N-His is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 18.8 kDa. The purity is>90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.

Specifications

Type Recombinant Protein
Species Chicken
Expression System E.coli
Purity >90% (SDS-PAGE)
Endotoxin <1 EU/μg (LAL)
Predicted Molecular Weight 18.8 kDa
Molecular Weight 18 kDa
Physical State Lyophilized
Formulation 20 mM Tris, 150 mM NaCl Buffer(pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01% SKL, 5% Trehalose and Proclin300)

Target Information

Fatty acid binding protein 2, also known as fatty acid-binding protein intestinal, is encoded by the FABP2 gene in chickens. Research showed that supplementing different levels of coated essential oils and organic acids mixture notably up-regulated FABP-2 mRNA levels in the ileum of the infected chickens after Salmonella Enteritidis challenge.

Protein Chicken Fatty Acid Binding Protein 2, Intestinal (FABP2)
Protein Synonym fatty acid binding protein 2, FABP, fatty acid-binding protein intestinal, intestinal fatty acid-binding protein
Gene ID 422678
UniProt ID Q7ZZZ5

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket